UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 特発性脳出血：治療および予後spontaneous intracerebral hemorrhage treatment and prognosis [show details]
… Intracerebral hemorrhage (ICH) is the second most common cause of stroke, following ischemic stroke. Mortality and morbidity is high. Initial goals of treatment include preventing hemorrhage extension …
2. 特発性脳出血：病因、臨床的特徴、および診断spontaneous intracerebral hemorrhage pathogenesis clinical features and diagnosis [show details]
… Intracerebral hemorrhage (ICH) is the second most common cause of stroke, trailing only ischemic stroke in frequency. There are many underlying pathological conditions associated with ICH; hypertension …
3. 脳卒中評価の概要overview of the evaluation of stroke [show details]
…bleeding disorder contributing to brain hemorrhages. Oral anticoagulant-related intracerebral hemorrhage is often lobar . Compared with spontaneous intracerebral hemorrhages, anticoagulant-related hemorrhages …
4. Prevention and treatment of venous thromboembolism in patients with acute strokeprevention and treatment of venous thromboembolism in patients with acute stroke [show details]
…prophylaxis. IPC is the mainstay for prevention of venous thromboembolism in patients with acute intracerebral hemorrhage (ICH) and should be started on admission . Once intracranial bleeding has stopped, some …
5. Paroxysmal sympathetic hyperactivityparoxysmal sympathetic hyperactivity [show details]
…sympathetic activity could pose a risk for end-organ damage (most notably in this setting, intracerebral hemorrhage). A variety of medications have been used to treat PSH. Some medications, such as beta…

Japanese Journal

新弾性接着剤（ＰＵＰ‐１３４，および２０１）の実質臓器出血に対する止血への応用および安全性確認

松田孝一,谷徹,沼謙司,阿部元,吉岡豊一,青木裕彦,小玉正智,松田武久,伊藤哲雄
人工臓器 19(3), 1231-1234, 1990
… 今回我々は、松田らにより血管吻合用に開発された医用弾性接着剤(PUP-134, 201)を用いて肝、脾、膵、腎臓の実質性出血に対する止血効果と止血手技および安全性につき検討した。 …
NAID 130001733494

Bleomydcin投与による実験的肺線維症の病理組織学的研究

大和田英美,香月秀雄,林豊
肺癌 10(4), 170-178, 1970
… Wister系ratにBLMの投与を行ない, その肺臓を病理組織学的に検索し, 次の結果を得た.<BR>肺組織の弾力線維の不規則な断裂消失巣と増生巣, 毛細血管の拡張, 実質性出血, 血管周囲の粗懸化, 脂肪顆粒細胞の出現, また胸膜下, 肺胞壁にはmast cellと酸性粘液多糖類の増加, 軽度の膠原線維の増生がみられた.<BR>これらの所見はBLMによる組織の変性崩壊と肺線維化としての結合織の増生を表わし, 肺線維化の過程を示唆する …
NAID 110003138565